EFTA01206023Set 9
2015-08-143p736w
change without notice. Additional information is available upon
request.
PZM 08/13 20:05 Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on
AVA-101 Program ... 08/13 20:24 *AVALANCHE WON'T INITIATE PHASE 2B TRIAL BN
08/13 20:19 *AVALANCHE BIOTECHNOLOGIES 2Q REV $0.2M, EST. $0.4M BN 08/13 20:05 *AVALANCHE
BIOTECHNOLOGIES ... LOSS/SHR 38C BN 08/13 20:05 *AVALANCHE BIOTECHNOLOGIES, REPORTS 2Q '15 FINANCIAL
RESULTS,
Avalanche Bio Falls After Scrapping Plans for Ph.2b Study
https://www.justice.gov/epstein/files/DataSet%209/EFTA01206023.pdf
EFTA00848760Set 9
2015-08-143p650w
change without notice. Additional information is available upon
request.
PZM 08/13 20:05 Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on
AVA-101 Program ... 08/13 20:24 *AVALANCHE WON'T INITIATE PHASE 2B TRIAL BN
08/13 20:19 *AVALANCHE BIOTECHNOLOGIES 2Q REV $0.2M, EST. $0.4M BN 08/13 20:05 *AVALANCHE
BIOTECHNOLOGIES ... LOSS/SHR 38C BN 08/13 20:05 *AVALANCHE BIOTECHNOLOGIES, REPORTS 2Q '15 FINANCIAL
RESULTS,
Avalanche Bio Falls After Scrapping Plans for Ph.2b Study
https://www.justice.gov/epstein/files/DataSet%209/EFTA00848760.pdf
EFTA01368503Set 10
2015-08-131p342w
request.
PZM 08/13 20:05 Avalanche Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update
on AVA-101 Program BFW 08/13 20:24 "AVALANCHE WON'T START ... 08/13 20:24 *AVALANCHE WON'T INITIATE PHASE 26
TRIAL BN 08/13 20:19 *AVALANCHE BIOTECHNOLOGIES 2Q REV $0.2M, EST. $0.4M BN 08/13 20:05 *AVALANCHE
BIOTECHNOLOGIES ... LOSS/SHR 38C BN 08/13 20:05 *AVALANCHE BIOTECHNOLOGIES, REPORTS 2Q'15 FINANCIAL
RESULTS,
Avalanche Bio Falls After Scrapping Plans for Ph.2b Study
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01368503.pdf
EFTA01412850Set 10
2015-08-144p585w
change without notice. Additional information is available
upon
request.
--+
PZM 08/13 20:05 Avalanche Biotechnologies, Inc. Reports Second Quarter 2015
Financial Results and Provides Update on AVA-101 Program ... 08/13 20:24 *AVALANCHE WON'T INITIATE PHASE 2B TRIAL BN 08/13 20:19
*AVALANCHE BIOTECHNOLOGIES 2Q REV $0.2M, EST. $0.4M BN 08/13 20:05
*AVALANCHE BIOTECHNOLOGIES ... LOSS/SHR 38C BN 08/13 20:05 *AVALANCHE
BIOTECHNOLOGIES, REPORTS 2Q '15 FINANCIAL RESULTS,
--+
Avalanche Bio Falls After Scrapping Plans for Ph.2b Study
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01412850.pdf
EFTA02361909Set 11
2015-08-131p92w
Richard Kahn
Sent: Thursday, August 13, 2015 9:03 PM
To: jeffrey E.
Subject: Avalanche Biotechnologies beats by $0.01, misses on revenue
Aug 13 2015, 16:45 ET I About ... Avalanche Biotechnologies (AAVL) <http://seekingalpha.com/symbol/AAVL> I By: Mohit
Manghnani <http://seekingalpha.com/author/sa-editor-mohit-manghnani> , SA News Editor
<http://seekingalpha.com/images/mail_icon.png>
• Avalanche Biotechnologies (NASDAQ:AAVL <http://seekingalpha.com/symbol/aavl
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02361909.pdf
EFTA00617222Set 9
2017-07-317p2,129w
Dress Bam 1.3.11) 1/16/01 70,500 1,500,000 151,575 164,970 -1.335.030
Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15
https://www.justice.gov/epstein/files/DataSet%209/EFTA00617222.pdf
EFTA00811552Set 9
2017-07-317p2,123w
Dress Bam 1.3.11) 1/16/01 70,500 1,500,000 151,575 164,970 -1.335.030
Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15
https://www.justice.gov/epstein/files/DataSet%209/EFTA00811552.pdf
EFTA00811530Set 9
2017-06-307p2,152w
Formerly Dress Barn 1.3.11) 1/16101 70.500 1.500.000 124,785 151,575 -1,348,425
Avalanche Biotechnologies now called Adverum Biotechnologies 4/20/15
https://www.justice.gov/epstein/files/DataSet%209/EFTA00811530.pdf